Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.8K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.8K
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

529
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
529
Drug toxicity: Drug–Drug Interaction01:30

Drug toxicity: Drug–Drug Interaction

341
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
341
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors01:13

Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors

1.3K
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
1.3K
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids01:31

Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids

951
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
951
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists01:28

Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

1.2K
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
1.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regional Variations in Mortality, Surgical Treatment, and Hospitalization in Children With Congenital Diaphragmatic Hernia: A European Population-Based Data-Linkage Cohort Study.

Birth defects research·2026
Same author

Response to Takahashi regarding Bestwick and Wald: Mischaracterisation of evidence in prostate cancer screening.

Journal of medical screening·2026
Same author

The Inherited Basis of Coronary Artery Disease.

The New England journal of medicine·2026
Same author

Corrigendum to Comprehensive clinical characteristics and outcomes of stage IV EGFR-mutant NSCLC based on PD-L1 expression, Cancer Treatment and Research Communications 46 (2026) 101109.

Cancer treatment and research communications·2026
Same author

Screening for prostate cancer.

Journal of medical screening·2026
Same author

Screening for Familial Hypercholesterolaemia.

European heart journal·2026

Related Experiment Video

Updated: Apr 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Grapefruit Juice and Statins.

Jonathan W Lee1, Joan K Morris1, Nicholas J Wald1

  • 1Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.

The American Journal of Medicine
|August 25, 2015
PubMed
Summary
This summary is machine-generated.

Grapefruit juice increases statin blood levels, enhancing cholesterol reduction and heart disease prevention. The study suggests grapefruit juice is not contraindicated for patients taking statins.

Keywords:
Drug interactionEffect enhancerGrapefruit juiceIschemic heart diseaseLDL cholesterolStatins

More Related Videos

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K

Related Experiment Videos

Last Updated: Apr 5, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.9K

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine
  • Clinical Pharmacy

Background:

  • Current medical guidelines often advise against consuming grapefruit juice with statin medications.
  • Statins are widely prescribed to lower cholesterol and reduce cardiovascular disease risk.
  • Grapefruit juice is known to interact with drug-metabolizing enzymes, potentially altering medication levels.

Purpose of the Study:

  • To evaluate the impact of grapefruit juice on the blood concentrations of simvastatin, lovastatin, and atorvastatin.
  • To determine the effect of concurrent grapefruit juice consumption on the efficacy of these statins in lowering LDL cholesterol and preventing heart disease.
  • To assess the safety profile, specifically the risk of rhabdomyolysis, associated with this interaction.

Main Methods:

  • Pharmacokinetic analysis of statin levels with and without grapefruit juice.
  • Calculation of estimated LDL cholesterol reduction and ischemic heart disease risk.
  • Comparison of risk-benefit analysis considering both cholesterol-lowering effects and potential adverse events.

Main Results:

  • Grapefruit juice significantly increases blood levels of simvastatin (260% concurrently, 90% 12 hours apart) and lovastatin (260% concurrently, 90% 12 hours apart).
  • Atorvastatin levels increase by approximately 80% when taken with grapefruit juice.
  • The combination enhances LDL cholesterol reduction and heart disease risk reduction, with increased rhabdomyolysis risk deemed minimal compared to cardiovascular benefits.

Conclusions:

  • Grapefruit juice consumption does not warrant a contraindication for patients taking simvastatin, lovastatin, or atorvastatin.
  • The enhanced cholesterol-lowering effect and cardiovascular risk reduction may outweigh the minimal increase in rhabdomyolysis risk.
  • Patients taking these statins can potentially consume grapefruit juice, but should consult their healthcare provider.